Association of APOE alleles and polygenic profiles comprising APOE ‐ TOMM40 ‐ APOC1 variants with Alzheimer's disease neuroimaging markers
Alzheimer's & Dementia · 2025-02 · 21 (2)
DOI: 10.1002/alz.14445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 23.12.2024. Verfasst von Alexander M Kulminski und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biodemography of Aging Research Unit, Social Science Research Institute, Duke University, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Apolipoprotein C-I, Membrane Transport Proteins, Brain. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, University of Kansas Alzheimer's Disease Research Center, NCATS NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION TOMM40 and APOC1 variants can modulate the APOE ‐ ε 4‐related Alzheimer's disease (AD) risk by up to fourfold. We aim to investigate whether the genetic modulation of ε 4‐related AD risk is reflected in brain morphology. METHODS We tested whether 27 magnetic resonance imaging‐derived neuroimaging markers of neurodegeneration (volume and thickness in temporo‐limbic regions) are associated with APOE‐TOMM40‐APOC1 polygenic profiles using the National Alzheimer's Coordinating Center Uniform Data Set linked to the AD Genetic Consortium data. RESULTS All brain regions studied using structural phenotypes were smaller in individuals with AD. The ε 4 allele was associated with smaller limbic (entorhinal, hippocampus, parahippocampus) brain volume and cortical thickness in AD cases than controls. There were significant differences in the associations for the higher‐risk and lower‐risk ε 4‐bearing APOE‐TOMM40‐APOC1 profiles with temporo‐limbic region markers. DISCUSSION The APOE ‐AD heterogeneity may be partly attributed to the modulating role of the TOMM40 and APOC1 genes in the APOE cluster. Highlights The ε 4 allele is associated with smaller values of neuroimaging markers in AD cases. Larger values of neuroimaging markers may protect against AD in the ε 4 carriers. TOMM40 and APOC1 variants differentiate AD risk in the ε 4 carriers. The same variants can differentiate the links between ε 4 and neuroimaging markers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biodemography of Aging Research Unit, Social Science Research Institute, Duke University, Durham, North Carolina, USA.
- Department of Neurology, University of Kansas School of Medicine, Kansas City, Kansas, USA.
- University of Kansas Alzheimer's Disease Center, University of Kansas School of Medicine, Kansas City, Kansas, USA.
- Department of Psychiatry, University of Kansas School of Medicine, Kansas City, Kansas, USA.
Förderung
- NIA NIH HHS
- University of Kansas Alzheimer's Disease Research Center
- NCATS NIH HHS
- Duke University
- NIGMS NIH HHS
- Alzheimer's Disease Genetics Consortium
- National Institute on Aging Genetics of Alzheimer's Disease
- National Institute on Aging
Zitieren
APA
Kulminski, A. M., Jain-Washburn, E., Nazarian, A., Wilkins, H. M., Veatch, O., Swerdlow, R. H., & Honea, R. A. (2025). Association of APOE alleles and polygenic profiles comprising APOE ‐ TOMM40 ‐ APOC1 variants with Alzheimer's disease neuroimaging markers. Alzheimer's & Dementia, 21(2). https://doi.org/10.1002/alz.14445
Vancouver
Kulminski AM, Jain-Washburn E, Nazarian A, Wilkins HM, Veatch O, Swerdlow RH, et al. Association of APOE alleles and polygenic profiles comprising APOE ‐ TOMM40 ‐ APOC1 variants with Alzheimer's disease neuroimaging markers. Alzheimer's & Dementia. 2025;21(2). doi:10.1002/alz.14445
BibTeX
@article{Kulminski2025,
author = {Kulminski, Alexander M and Jain-Washburn, Ethan and Nazarian, Alireza and Wilkins, Heather M and Veatch, Olivia and Swerdlow, Russell H and Honea, Robyn A},
title = {Association of APOE alleles and polygenic profiles comprising APOE ‐ TOMM40 ‐ APOC1 variants with Alzheimer's disease neuroimaging markers},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {2},
doi = {10.1002/alz.14445}
}
EUVIMED